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Abstract
Surfactant protein concentrations are precisely maintained during fetal development and postnatally controlled, at least in
part, by the regulation of gene transcription and/or mRNA stability. Together, these mechanisms contribute to the unique
temporal-spatial distribution of surfactant protein synthesis that is characteristic of the mammalian lung. Surfactant proteins
A, B and C are expressed primarily in subsets of respiratory epithelial cells, wherein their expression is modified by
developmental, physiological, humoral and inflammatory stimuli. Cell specific and humoral regulation of surfactant protein
transcription is determined by the interactions of a number of nuclear transcription proteins that function in combination, by
binding to cis-acting elements located in the 5P regulatory regions of each of the surfactant protein genes. The unique
combination of distinct and shared cis-acting elements and transcriptional proteins serves to modulate surfactant protein
synthesis in the lung. The present review will summarize efforts to identify the mechanisms contributing to the regulation of
surfactant protein gene transcription in the lung, focusing to the nuclear transcription factor, TTF-1 (or thyroid transcription
factor-1), a member of the NkM2 family of nuclear transcription proteins. A complete review of regulatory aspects of
surfactant homeostasis is beyond the scope of the present summary. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Expression of surfactant proteins A, B and C
The cloning of cDNAs encoding the surfactant
proteins provided the reagents with which to de¢ne
the precise temporal-spatial patterns of surfactant
protein gene expression in the lung (see [1,2] for re-
view). The isolation and characterization of the genes
encoding each of the proteins in turn has provided
insights into the molecular mechanisms that govern
their transcription. Study of gene transcription in
vitro has been facilitated by the development of pul-
monary adenocarcinoma cell lines (H441 and MLE
cells) that are now widely used for the analysis of
surfactant protein gene transcription. These cell lines
express surfactant proteins A, B or C in vitro and are
amenable to transfection of DNA [3]. In a second
advance, the use of transgenic mice, wherein the
cis-acting elements of surfactant protein genes have
been permanently inserted into the mouse genome,
has facilitated the study of the transcriptional ele-
ments from the surfactant protein and CCSP (Clara
cell secretory protein) gene in vivo [4].
2. Expression of surfactant protein genes in Type II
cells is regulated by extracellular signals
Rapid advances are being made in determining
how speci¢c transcription factor complexes associate
with target binding sites to e¡ect cell speci¢c expres-
sion of surfactant protein genes. The maintenance of
Type II cell speci¢c expression of surfactant protein
genes is also highly dependent on signals provided by
cell-cell, cell-extracellular matrix, and growth factor
stimulation in the alveolar microenvironment. Iso-
lated Type II cells grown by conventional tissue cul-
ture techniques rapidly loose expression of SP-A,
SP-B and SP-C. Culture under conditions that main-
tain Type II cell shape prolongs surfactant protein
gene expression and Type II cell di¡erentiation in
vitro. Isolated Type II cells cultured on a three di-
mensional substrata of fetal lung ¢broblasts im-
bedded in rat tail collagen matrix and maintained
as a free £oating gel maintain a cuboidal Type II
cell phenotype and sustain expression of SP-A,
SP-B and SP-C mRNA [5]. The precise cell shape
and contact requirements provided in these experi-
ments suggest that organization of the Type II cell
cytoskeleton may in£uence surfactant protein gene
expression. Disruption of micro¢laments or microtu-
bules in these cultures reduced SP-A, SP-B and SP-C
mRNA levels [6]. Primary cultures of Type II cells
supplemented with keratinocyte growth factor
(KGF) increased SP-A, SP-B and SP-D mRNA lev-
els but not SP-C mRNA [7,8]. When puri¢ed epithe-
lial rudiments from fetal rat lungs were cultured in
media supplemented with KGF, SP-C mRNA ex-
pression was detected by in situ hybridization sug-
gesting that KGF in£uences di¡erentiation of Type
II cells in vitro [9].
3. Regulation of surfactant protein gene expression by
in£ammatory mediators
Decreased surfactant function is a common com-
plication in recovery from in£ammatory lung dis-
eases that include ARDS and bacterial infections.
Surfactant is inactivated by the leakage of serum
proteins into the alveoli. Increased alveolar-capillary
permeability and the release of various cytokines
may in£uence surfactant function and expression.
Intratracheal instillation of a single dose of TNF
decreased SP-A, SP-B and SP-C mRNA levels in
vivo. Likewise, TNF-K and phorbol esters reduced
the SP-A and SP-B mRNA [10] in pulmonary adeno-
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carcinoma cells by mechanisms independent of
NFkB activation [11]. In MLE cells, TNF-K de-
creased SP-C mRNA levels and decreased the tran-
scriptional activity of SP-C promoter constructs. The
cis-acting element mediating inhibitory e¡ects of
TNF-K on SP-C gene transcription was mapped to
within 320 bp of the start of transcription [12].
4. Transcription factors determine surfactant protein
gene expression
Transcription proteins exert their e¡ects on gene
expression by binding directly or indirectly to cis-
acting elements often located near or within the
gene locus in the chromosome. Proteins binding to
DNA may in£uence chromatin structure generally or
speci¢cally, by altering protein-DNA interactions
that in£uence function of the basal transcriptional
complex usually located near the start of transcrip-
tion in pol II dependent promoters. Analysis of
the mechanisms underlying surfactant protein B
gene expression has been particularly useful in
identifying the role of several transcription factors
controlling surfactant protein gene expression [13].
TTF-1, a 38 kDa homeodomain containing tran-
scription factor and a member of NkM2 family of
nuclear transcription proteins, binds to and activates
promoters of the surfactant proteins A [14], B [13], C
[15] and CCSP (Clara cell secretory protein) [16]
genes (Figs. 1 and 2). In the thyroid, TTF-1 activates
the transcription of thyroglobin, thyroperoxidase
and the sodium-iodide (Na/I) transport protein [17^
19].
4.1. TTF-1 binds to complex cis-acting elements
TTF-1 binds to consensus elements CAAG located
at multiple sites in the 5P £anking regions of the
target genes presently identi¢ed [13^15]. Sites are
Fig. 1. The murine SP-C promoter is activated by the transcription factor TTF-1. Cat assays of extracts from cells that were transi-
ently co-transfected with chloramphenicol acetyl transferase (CAT) reporter plasmids under control of di¡erent promoters in the pres-
ence (+) or absence (3) of a TTF-1 producing plasmid demonstrate that TTF-1 selectively activates the SP-C promoter. Acetylated re-
action products (upper spots) are separated from the unreacted chloramphenicol substrate (lower spots) by thin layer
chromatography. Assays were normalized for transfection e⁄ciency to L-galactosidase activity produced by a control plasmid. The
pBLCAT6 plasmid is the promoterless CAT reporter vector. CAT activity from pBLCAT6 extracts demonstrates minimal reporter ac-
tivity which is not a¡ected by co-expression of TTF-1. Speci¢c activation of the SP-C promoter by TTF-1 is demonstrated in the next
two sets of CAT assays. A pBLCAT6 plasmid containing 4.8 kb of the murine SP-C promoter and upstream sequence (pmu4.8CAT)
drives low level expression in the absence of TTF-1 while co-expression of TTF-1 stimulates a 10-fold increase in SP-C-CAT activity.
The selective response of the SP-C promoter to TTF-1 transactivation is further demonstrated by the assays labeled pBLCAT5, where
the CAT reporter gene is under control of the herpes simplex virus thymidine kinase gene promoter (HSV-TK). Basal levels of HSV-
TK driven expression is higher than unstimulated 4.8 SP-C expression but the HSV-TK promoter is unresponsive to stimulation by
TTF-1. Assays of duplicate transfections are shown side by side.
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often clustered in groups of two or more binding
sites that serve as cell speci¢c elements or enhancers
(Fig. 3). TTF-1 sites are often found in close prox-
imity to binding sites for other nuclear transcription
proteins, including the retinoic acid receptor element
(RARE), HNF-3 (hepatocyte nuclear factor family
members), AP-1, CREB, myb, etc. Binding of these
various nuclear transcription factors, singly or in
combination, may (1) stabilize higher order com-
plexes with TTF-1, (2) interfere with or enhance
TTF-1 binding or function, or (3) alter chromatin
structure in the region to change DNA binding pro-
tein interactions that in£uence gene transcription
positively or negatively.
Several other modi¢cations of the TTF-1 protein
have been identi¢ed that in£uence TTF-1 function
and may add to the complexity of surfactant protein
regulation. TTF-1 has the ability to form covalently
linked dimers and oligomers that have reduced DNA
binding a⁄nity [20]. TTF-1 binding activity is also
a¡ected by redox regulation. Oxidation of TTF-1
reduced TTF-1 binding a⁄nity [20]. A diversity of
TTF-1 molecules may also be generated at the level
of transcription. Analysis of TTF-1 genomic sequen-
ces provides evidence that at least two distinct tran-
scription start sites can generate alternative TTF-1
mRNA isoforms. cDNA clones encoded by tran-
scription from both TTF-1 promoters have been re-
cently identi¢ed and partially characterized [21,22]. It
is unknown if the TTF-1 encoded by these longer
transcripts has altered binding and activation activ-
ity.
In general, mutations of TTF-1 binding sites in the
proximal promoter regions of the surfactant protein
genes, markedly inhibit lung cell speci¢c transcrip-
tional activity. For example, mutagenesis of a prox-
imal element located 380 to 3100 of the SP-B pro-
moter completely blocked SP-B gene transcription in
vitro. On the other hand, mutation of the TTF-1
binding sites located in the enhancer element 3400
in the SP-B gene inhibits, but does not ablate, cell
selective activity of the SP-B promoter [13,23]. Thus
Fig. 2. Fusion of SP-C sequences to HSV-TK promoter constructs de¢nes the TTF-1 responsive region. The TTF-1 responsive region
of the SP-C promoter was mapped by deletion analysis to 3320 bp of the transcription start site [15]. This region was then tested for
its ability to confer TTF-1 responsiveness on the HSV-TK promoter. In transient co-transfection experiments the unaltered HSV-TK
promoter (pBLCAT5) was not stimulated by co-expression of TTF-1. When a 72 bp fragment of SP-C DNA spanning the candidate
TTF-1 elements was fused to the TK promoter (p 70 TK-CAT), TTF-1 (+) stimulated CAT expression over expression levels obtained
in the absence of TTF-1 (3). Oligomerization of three copies of the 72 bp region on the HSV-TK promoter plasmid increased the
magnitude of TTF-1 transactivation (p 3U70 TK-CAT). The TTF-1 responsive region of the SP-C promoter was further subdivided
and analyzed by site speci¢c mutagenesis and biochemical analysis to de¢ne sites of TTF-1 binding and activation.
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the proximal element serves to maintain cell selective
expression and the distal element serves to act as a
lung cell selective enhancer. Mutation of a HNF-3
binding site located near the TTF-1 site in the SP-B
gene promoter also markedly inhibited gene tran-
scription [13]. This element is located near a site of
DNAse hypersensitivity, suggesting that the binding
of HNF-3L alters chromatin structure, allowing
unique combinatorial interactions among various
transcription factors at the site. In general, complex
combinatorial interactions among a number of nu-
clear transcription proteins and their binding sites,
achieves control of surfactant protein gene expres-
sion in a cell selective manner.
4.2. Phosphorylation of TTF-1
TTF-1 is phosphorylated by both cAMP and cal-
cium activated protein kinase in both thyroid and
respiratory epithelial cells [24,25]. Phosphorylation
sites have been mapped by mutagenesis studies, iden-
tifying the regions in both the amino and carboxy
terminal domains that are phosphorylated [24,25].
TTF-1 is also phosphorylated by the rat homolog
of the MST kinases [26]. MST (mammalian sterile)
kinases are a distinct family of ubiquitous serine/
threonine kinases. The MST kinases are not mem-
bers of the mitogen activated protein kinases nor of
the stress activated kinases. Thus, TTF-1 is a unique
target of a constitutive protein kinase. Cyclic AMP
increases the surfactant protein A and B gene expres-
sion in fetal lung explants and in adenocarcinoma
cells in vitro. Co-transfection of pulmonary adeno-
carcinoma cells with a plasmid expressing the cata-
lytic subunit of cAMP dependent protein kinase, cat-
L activates SP-B expression in association with phos-
phorylation of TTF-1 [25]. E¡ects of cAMP on gene
transcription are also modulated by binding of
CREB to CRE elements in a number of target genes.
However in pulmonary adenocarcinoma cells, co-
transfection with CREB inhibited SP-B gene tran-
scription. Thus, the e¡ects of cAMP, at least in
part, are regulated by a TTF-1 dependent mechanism
rather than through CRE occupancy. C kinase activ-
ity also phosphorylates TTF-1; however, the precise
regulatory role of this phosphorylation remains un-
clear.
4.3. Nuclear localization of TTF-1
Staining for TTF-1 is con¢ned to the nuclei of cells
in the central nervous system, thyroid and respira-
tory epithelial cells [27]. Site directed mutagenesis of
the TTF-1 polypeptide identi¢ed the regions involved
in nuclear transport, residing in the amino terminus
and homeodomain regions of the molecule [28]. Since
TTF-1 concentrations in£uence the occupancy of the
nuclear complexes at TTF-1 binding sites and target
genes, changes in the nuclear concentration of TTF-1
may strongly in£uence surfactant protein gene ex-
pression. Recent work demonstrated decreased nu-
clear staining of both TTF-1 and HNF-3L in adeno-
carcinoma cells treated with phorbol esters. These
studies suggest that cytoplasmic trapping of the tran-
scription factors perhaps mediated by changes in
phosphorylation, contribute to changes in surfactant
protein gene expression in this model [29].
4.4. Pattern of HNF-3L and TTF-1 expression in the
respiratory epithelium supports their role in
organogenesis and surfactant protein gene
expression
TTF-1 is expressed early in pulmonary organogen-
esis, being detected in the nuclei of epithelial cells in
the lung primordia at the onset of lung formation
[27,30]. TTF-1 gene transcription is induced by
HNF-3L [31], the latter gene being critical to forma-
tion of the dorsal-ventral axis and foregut endoderm
[32]. TTF-1 is expressed in the developing lung buds
and is increasingly restricted to the periphery of res-
piratory tubules during lung development. Expres-
sion of TTF-1 decreases in the postnatal lung, being
detected primarily in Type II cells in the alveolus,
and being absent in Type I cells in the postnatal
lung [30,33]. Gene targeting of TTF-1 in transgenic
mice caused severe pulmonary hypoplasia, associated
with an absence of expression of surfactant proteins
in the remaining epithelium [34]. While lung paren-
chyma was completely ablated in the TTF-1 (3/3)
mice, the trachea and proximal bronchi were rela-
tively intact. The temporal-spatial distribution of
TTF-1 and its demonstrated critical role in the for-
mation of the lung parenchyma supports its primary
role as a determinant of lung morphogenesis, as well
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Fig. 3. Multiple protein to DNA interactions on the proximal SP-C promoter contribute to regulation of SP-C transcription. The con-
¢gurations of known cis-active regulatory elements are diagramed relative to the transcription start site (arrow). Boxed regions labeled
C1 to C5 denote sites of protein-DNA interaction determined by DNAse footprint analysis. Brackets indicate functionally de¢ned reg-
ulatory regions (TTF-1 responsive and cell selective enhancer). Known transcription factor binding sites are indicated on SP-C se-
quence expanded below the indicated footprint sites. An extended NFI site in footprint C1 and NFI half site in C3 are required for
basal SP-C promoter activity. Essential TTF-1 binding sites are indicated below footprint C2. Multiple protein interactions are de-
tected in the SP-C enhancer which co-localizes to footprints C4^C5. In both C4 and C5 an NFI family member binds to a half site
motif while an unknown factor(s) bind to an adjacent AAGA sequence. How the enhancer region interacts with proximal elements to
confer precise cell speci¢c transcription is unknown. Arrows indicate the relative orientation of consensus binding site motifs on the
coding strand.
Fig. 4. Summary of transcription factor binding sites associated with genes that are expressed in the lung. The location of transcrip-
tion factor binding sites are shown relative to the basal promoter and transcription start site (+1) of surfactant proteins A, B, C,
Clara cell secretory protein, and thyroid transcription factor 1 genes. Binding sites are identi¢ed for TTF-1 (T), hepatocyte nuclear
factor 3L (H), SV40 promoter factors (SP) SP-1, SP-3, and nuclear factor 1 (N). The number and position of binding sites for a spe-
ci¢c factor is di¡erent for each gene expressed selectively in the lung. These data suggest that the di¡erent combinations of factors ef-
fect the distinct patterns and levels of expression of each gene. Data has been obtained for the murine SP-A and SP-C genes, human
SP-B and TTF-1 genes, and murine CCSP gene.
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as respiratory epithelial cell di¡erentiation and sur-
factant protein gene expression. TTF-1 expression is
increased in regenerating respiratory tubules follow-
ing lung injury, being detected at high levels in the
respiratory epithelial buds in infants with cystic ¢b-
rosis, bronchopulmonary dysplasia and other forms
of severe lung injury.
4.5. Transcriptional activation of surfactant protein
gene expression by NFI
The nuclear factor I (NFI) family of transcription
factors consists of four distinct genes, each of which
is di¡erentially spliced to produce multiple isoforms
of NFI. NFI was originally identi¢ed as a transcrip-
tion factor that activated adenoviral gene expression.
NFI has subsequently been shown to be expressed in
many organs and to activate a large number of mam-
malian genes. NFI expression in the developing
mouse lung was examined by in situ hybridization
using probes speci¢c for each of four NFI genes
[35]. NFI mRNA was detected by fetal day 11.5
and increased during lung development. The NFI-B
gene was expressed at highest levels in the developing
lung. Lower levels of NFI-A, NFI-C and NFI-M
mRNA expression were detected and localized to
multiple cell types.
Multiple NFI consensus binding half sites
(TGGCA) were associated with DNAse I protected
regions of the SP-C promoter and suggested a role
for NFI in activating SP-C gene expression [36]. Mu-
tations of NFI sites in a region located 3312 to 397
in the SP-C promoter inhibited activation by NFI.
These results are summarized in Figs. 3 and 4. Di¡er-
ential splicing of four NFI genes can produce 18
distinct isoforms of NFI that have been identi¢ed
to date. Furthermore, NFI proteins form homo-
dimers or heterodimers that may in£uence surfactant
protein gene expression.
5. Role of glucocorticoids
Maternal corticosteroids are routinely used to pre-
vent RDS in preterm infants and are used postna-
tally to enhance lung function in preterm infants
with bronchopulmonary dysplasia. Glucocorticoids
enhance surfactant protein B and C mRNA in fetal
lung explants and in cell culture in vitro and in vivo
[37^40]. Both inhibitory and stimulatory e¡ects
of glucocorticoids have been observed on SP-A
mRNA production and are mediated by changes in
mRNA stability and/or gene transcription [41^44].
The e¡ects of glucocorticoids on surfactant protein
expression vary with cell type, dose and species. Ef-
fects of glucocorticoids in H441 cells are modulated
primarily by changes in SP-B mRNA stability rather
than by gene transcription [40]. Glucocorticoid de-
pendent changes in surfactant protein gene transcrip-
tion are modest and are likely mediated indirectly
rather than by direct binding of the glucocorticoid
receptor (GR) to the surfactant protein genes. Sur-
factant protein mRNA and immunostaining are vir-
tually unaltered in GR (3/3) mice generated by gene
targeting [45]. These results demonstrate that the GR
is not required for surfactant protein gene expression
in the perinatal and postnatal periods. Mice with a
targeted mutation of the corticotrophin releasing fac-
tor (CRF) gene were reported with immature lungs
and a 44% reduction in SP-B mRNA [46]. These
results are distinct from the direct mutation of the
GR gene where the levels of SP-A, SP-B, SP-C
mRNA expression and the tempo-spacial patterns
of SP-B and SP-C expression were unchanged.
6. Respiratory adaptation and surfactant protein gene
expression
Surfactant proteins play important roles in host
defense (SP-A and SP-D), and surfactant function
and metabolism (SP-B and SP-C). Evidence from
mice with targeted disruption of SP-A or SP-B dem-
onstrate the critical role of gene dosage in mRNA
expression [47,48]. Heterozygous SP-A (+/3) and
heterozygous SP-B (+/3) mice express approximately
50% of protein and mRNA in neonates and/or adults
compared to wild-type littermates. Even a 50% re-
duction in surfactant protein B mRNA and protein
caused discernable changes in lung function in vivo
[49]. SP-B (+/3) mice are susceptible to lung injury
following oxygen exposure and have decreased lung
compliance, under normal vivarium conditions [50].
Thus, changes in surfactant protein expression ac-
company lung di¡erentiation, oxygen toxicity,
ARDS, RDS, lung in£ammation, and infection. It
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is hoped that understanding mechanisms controlling
surfactant protein production will provide the basis
for strategies to optimize surfactant concentrations in
clinical settings, whether by replacement of surfac-
tant proteins or by modulation of surfactant protein
gene transcription or mRNA stability.
7. Unresolved issues and future perspectives
The surfactant protein genes are expressed in dis-
tinct subsets of di¡erentiated cells. SP-A, SP-B and
SP-C are expressed in the alveolar Type II cells,
while SP-A and SP-B are also expressed in distal
airway epithelial cells. Our knowledge of how these
genes are di¡erentially expressed is incomplete.
Functional analysis of the surfactant protein gene
promoters in mouse lung epithelial cell lines have
provided the ¢rst evidence as to how cell speci¢c
expression is achieved. Co-transfection experiments
demonstrated that the transcription factor TTF-1 ac-
tivated the surfactant protein gene promoters. Selec-
tive activation by TTF may be due to di¡erential
phosphorylation of TTF, distinct isoforms of TTF-
1 and varying cellular concentrations of TTF-1. Spe-
ci¢c activation by TTF-1 may also be conferred by
the distinct arrays of TTF-1 binding sites consisting
of di¡erent numbers, orientations and binding site
a⁄nities for TTF-1 in each promoter region exam-
ined. While speci¢city of expression can be generated
by unique TTF-1 transcriptional complexes other
factors play a central role in cell speci¢c and precise
temporal-spacial activation of surfactant protein
genes. HNF-3L stimulates human SP-B expression
and also stimulates TTF-1 gene expression. HNF-
3L is expressed in the developing foregut endoderm
and is one of a larger family of HNF and HFH
(HNF homolog) transcription factors that are ex-
pressed in the developing lung. In addition, the SP-
C promoter has been shown to be stimulated by NFI
family members. All four NFI genes are expressed in
the lung producing numerous distinct isoforms which
could selectively modify patterns of expression.
These data provide insights into a network of regu-
latory molecules involving variants of tissue re-
stricted and ubiquitous transcription factors which
bind and activate cell speci¢c expression of surfac-
tant protein genes. These in vitro experimental ap-
proaches will not elucidate the role of higher ordered
chromatin structure in e¡ecting regulated access to
DNA binding sites or the dynamic positioning of
distal enhancers relative to cell selective regulatory
elements. The use of transgenic mice for in vivo pro-
moter studies will be necessary to identify the chro-
matin dependent regulatory events that complement
the transcription factor binding studies described in
this report.
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